Jordyn Tarazi | Director of Investor Relations |
Joe Sarret | Chief Executive Officer |
Ken Cundy | Chief Scientific Officer |
Jeff Biunno | Chief Financial Officer |
Nathan Weinstein | Aegis Capital |
Elemer Piros | ROTH Capital Partners |
Steve Brozak | WBB Securities |
Good afternoon. My name is Chuck, and I will be your conference operator today. At this time, I would like to welcome everyone to CohBar’s Second Quarter 2021 Financial Results and Clinical Trial Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions.